LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that, based on verbal notice from NASDAQ, it expects to receive a NASDAQ Staff Determination Letter indicating that the company is not in compliance with Marketplace Rule 4310(c)(14), which requires timely filing of periodic reports for continued listing. Upon receipt, the company will request a hearing before the NASDAQ Listing Qualifications Panel.
